Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

PRLDPRLD
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in PRELUDE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 120,834 shares of PRLD (PRELUDE THERAPEUTICS INC), worth $644,045 as of 2026-Q2. The position was decreased (-48.9% shares). PRLD represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$644,045

Current Shares

120,834

Total Value Change

+$454,929

Total Shares Change

-27,492

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
120,834
-48.9%
$644,0450.0%$5.33
0
2026-Q1
Increased
236,469
+101.3%
$808,7240.0%$2.63
40
2025-Q4
Increased
117,477
+48.1%
$340,6830.0%$2.84
22
2025-Q3
Decreased
79,327
-46.8%
$114,2310.0%$1.37
0
2025-Q2
Decreased
149,178
-3.9%
$120,7450.0%$0.79
0
2025-Q1
Increased
155,215
+4.6%
$119,2050.0%$0.80
16
2024-Q4
New
148,326
-
$189,1160.0%$1.21
35

Other major holders of PRLD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used